Prima BioMed Net Worth 2006-2020 | IMMP
Interactive chart of historical net worth (market cap) for Prima BioMed (IMMP) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Prima BioMed net worth as of October 20, 2021 is $0.37B.
||Medical - Biomedical and Genetics
Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.